Lung function decline in COPD trials: bias from regression to the mean
Author:
- S. SuissaSSS. Suissa
Open Access
- 30 September 2008
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 32 (4) , 829-831
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH StudyAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 2007
- A Pooled Analysis of FEV 1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or PlaceboChest, 2007
- Clinical Trial Design Considerations in Assessing Long‐Term Functional Impacts of Tiotropium in COPD: The Uplift TrialCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2004
- Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysisThorax, 2003
- Long-Term Effects of Inhaled Corticosteroids on FEV1 in Patients with Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 2003
- Statistics Notes: Some examples of regression towards the meanBMJ, 1994